Search research articles
Contact Us
Filters
Showing results (21-30 of 50) with videos related to
Page
of 5
Sort By:
Oncogene
|
March 21, 1996
Expression of the jun family of genes in human ovarian cancer and normal ovarian surface epithelium
B Neyns, Katesuwanasing, J Vermeij, et al.
The British Journal of Dermatology
|
May 13, 2014
Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?
I Chevolet, R Speeckaert, M Haspeslagh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 6, 2010
Phase II study of helical tomotherapy for oligometastatic colorectal cancer
B Engels, H Everaert, T Gevaert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2013
Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials
J D Wolchok, J S Weber, M Maio, et al.
European Journal of Radiology Open
|
March 28, 2024
Differentiation between normal and metastatic lymph nodes in patients with skin melanoma: Preliminary findings using a DIXON-based whole-body MRI approach
C Brussaard, L Faggioni, F E Ramirez-Barbosa, et al.
Journal of Neuro-Oncology
|
September 28, 2010
Phase II study of sunitinib malate in patients with recurrent high-grade glioma
B Neyns, J Sadones, C Chaskis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 2, 2013
A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
S Wilgenhof, A M T Van Nuffel, D Benteyn, et al.
Oncoimmunology
|
May 8, 2015
Characterization of the <i>in vivo</i> immune network of IDO, tryptophan metabolism, PD-L1, and <i>CTLA-4</i> in circulating immune cells in melanoma
I Chevolet, R Speeckaert, M Schreuer, et al.
Journal of Oncology
|
April 7, 2012
An observational study of the first experience with bevacizumab for the treatment of patients with recurrent high-grade glioma in two belgian university hospitals
M Huylebrouck, S Lv, J Duerinck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2014
Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies
C Lebbé, J S Weber, M Maio, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 50) with videos related to
Sort By:
Page
of 5
Oncogene
|
March 21, 1996
Expression of the jun family of genes in human ovarian cancer and normal ovarian surface epithelium
B Neyns, Katesuwanasing, J Vermeij, et al.
The British Journal of Dermatology
|
May 13, 2014
Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?
I Chevolet, R Speeckaert, M Haspeslagh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 6, 2010
Phase II study of helical tomotherapy for oligometastatic colorectal cancer
B Engels, H Everaert, T Gevaert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2013
Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials
J D Wolchok, J S Weber, M Maio, et al.
European Journal of Radiology Open
|
March 28, 2024
Differentiation between normal and metastatic lymph nodes in patients with skin melanoma: Preliminary findings using a DIXON-based whole-body MRI approach
C Brussaard, L Faggioni, F E Ramirez-Barbosa, et al.
Journal of Neuro-Oncology
|
September 28, 2010
Phase II study of sunitinib malate in patients with recurrent high-grade glioma
B Neyns, J Sadones, C Chaskis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 2, 2013
A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
S Wilgenhof, A M T Van Nuffel, D Benteyn, et al.
Oncoimmunology
|
May 8, 2015
Characterization of the <i>in vivo</i> immune network of IDO, tryptophan metabolism, PD-L1, and <i>CTLA-4</i> in circulating immune cells in melanoma
I Chevolet, R Speeckaert, M Schreuer, et al.
Journal of Oncology
|
April 7, 2012
An observational study of the first experience with bevacizumab for the treatment of patients with recurrent high-grade glioma in two belgian university hospitals
M Huylebrouck, S Lv, J Duerinck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2014
Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies
C Lebbé, J S Weber, M Maio, et al.
Page
of 5